Seroepidemiology of Hepatitis B in Greek Children 6 Years After the Implementation of Universal Vaccination

The seroepidemiology of hepatitis B in children living in Greece 6 years post-implementation of universal infant immunization (1998) was studied. We collected 90–100 sera/year of age, stratified by geographic region. The prevalence of HbsAg(+) was 0.6% (95% CI 0.3–1.3) whereas 4.5% (95% CI 3.4–5.9%)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Infection 2008-04, Vol.36 (2), p.135-139
Hauptverfasser: Papaevangelou, V., Hadjichristodoulou, C., Cassimos, D. C., Pantelaki, K., Tzivaras, A., Hatzimichael, A., Theodoridou, M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 139
container_issue 2
container_start_page 135
container_title Infection
container_volume 36
creator Papaevangelou, V.
Hadjichristodoulou, C.
Cassimos, D. C.
Pantelaki, K.
Tzivaras, A.
Hatzimichael, A.
Theodoridou, M.
description The seroepidemiology of hepatitis B in children living in Greece 6 years post-implementation of universal infant immunization (1998) was studied. We collected 90–100 sera/year of age, stratified by geographic region. The prevalence of HbsAg(+) was 0.6% (95% CI 0.3–1.3) whereas 4.5% (95% CI 3.4–5.9%) of children over 12 months of age had evidence of past HBV infection. A significant decline in the prevalence of past infection between children born before and after 1998 (5.5% vs 2.9%; RR = 1.9, 95% CI 1.03–3.5) was noted. Conversely, the prevalence of past HBV infection did not change significantly among immigrant children. Reinforcement of early vaccination of immigrant population is necessary.
doi_str_mv 10.1007/s15010-007-7096-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69103576</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1470177791</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-c08f76bd0a88fa54809d0e2d0ef37b80ede911ee1c52d97831f66871f24582903</originalsourceid><addsrcrecordid>eNqFkU1rFTEUhoMo9lr9AW4kuHA3ek4yk49lvWhbKLjQCq7C3JmTNu1MMiZzhf57Z7wXCoK4CDlwnvcJ4WXsNcJ7BNAfCjaAUC1jpcGqSj1hG6ylrcBq-ZRtQAJUBoU6YS9KuQOAxtb6OTtBIyRqNBt2_5Vyoin0NIY0pJsHnjy_oKmdwxwK_8hD5OeZ6J5vb8PQZ4pc8R_U5sLP_EyZz7fEL8dpoJHivKRSXA3XMfyiXNqBf2-7LsQ_i5fsmW-HQq-O9ym7_vzp2_aiuvpyfrk9u6q6GmCuOjBeq10PrTG-bWoDtgcSy_FS7wxQTxaRCLtG9FYbiV4po9GLujHCgjxl7w7eKaefeyqzG0PpaBjaSGlfnLIIstHqv6AAo-sGxQK-_Qu8S_scl084gY1CWdvVhgeoy6mUTN5NOYxtfnAIbu3LHfpy67j25dbMm6N4vxupf0wcC1oAcQDKsoo3lB9f_rf1N8Sgn0I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>215613496</pqid></control><display><type>article</type><title>Seroepidemiology of Hepatitis B in Greek Children 6 Years After the Implementation of Universal Vaccination</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Papaevangelou, V. ; Hadjichristodoulou, C. ; Cassimos, D. C. ; Pantelaki, K. ; Tzivaras, A. ; Hatzimichael, A. ; Theodoridou, M.</creator><creatorcontrib>Papaevangelou, V. ; Hadjichristodoulou, C. ; Cassimos, D. C. ; Pantelaki, K. ; Tzivaras, A. ; Hatzimichael, A. ; Theodoridou, M.</creatorcontrib><description>The seroepidemiology of hepatitis B in children living in Greece 6 years post-implementation of universal infant immunization (1998) was studied. We collected 90–100 sera/year of age, stratified by geographic region. The prevalence of HbsAg(+) was 0.6% (95% CI 0.3–1.3) whereas 4.5% (95% CI 3.4–5.9%) of children over 12 months of age had evidence of past HBV infection. A significant decline in the prevalence of past infection between children born before and after 1998 (5.5% vs 2.9%; RR = 1.9, 95% CI 1.03–3.5) was noted. Conversely, the prevalence of past HBV infection did not change significantly among immigrant children. Reinforcement of early vaccination of immigrant population is necessary.</description><identifier>ISSN: 0300-8126</identifier><identifier>EISSN: 1439-0973</identifier><identifier>EISSN: 1439-0972</identifier><identifier>DOI: 10.1007/s15010-007-7096-6</identifier><identifier>PMID: 18231718</identifier><language>eng</language><publisher>Munich: Urban &amp; Vogel</publisher><subject>Adolescent ; Analysis of Variance ; Chi-Square Distribution ; Child ; Child, Preschool ; Clinical and Epidemiological Study ; Family Medicine ; General Practice ; Greece - epidemiology ; Hepatitis ; Hepatitis B - epidemiology ; Hepatitis B - prevention &amp; control ; Hepatitis B Antibodies - blood ; Hepatitis B Core Antigens - immunology ; Hepatitis B Surface Antigens - analysis ; Hepatitis B Vaccines - administration &amp; dosage ; Hepatitis B Vaccines - immunology ; Hepatitis B virus ; Hepatitis B virus - immunology ; Humans ; Immunization ; Infant ; Infant, Newborn ; Infectious Diseases ; Internal Medicine ; Longitudinal Studies ; Mass Vaccination ; Medicine ; Medicine &amp; Public Health ; Seroepidemiologic Studies ; Vaccines</subject><ispartof>Infection, 2008-04, Vol.36 (2), p.135-139</ispartof><rights>Urban &amp; Vogel München 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-c08f76bd0a88fa54809d0e2d0ef37b80ede911ee1c52d97831f66871f24582903</citedby><cites>FETCH-LOGICAL-c400t-c08f76bd0a88fa54809d0e2d0ef37b80ede911ee1c52d97831f66871f24582903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s15010-007-7096-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s15010-007-7096-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18231718$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Papaevangelou, V.</creatorcontrib><creatorcontrib>Hadjichristodoulou, C.</creatorcontrib><creatorcontrib>Cassimos, D. C.</creatorcontrib><creatorcontrib>Pantelaki, K.</creatorcontrib><creatorcontrib>Tzivaras, A.</creatorcontrib><creatorcontrib>Hatzimichael, A.</creatorcontrib><creatorcontrib>Theodoridou, M.</creatorcontrib><title>Seroepidemiology of Hepatitis B in Greek Children 6 Years After the Implementation of Universal Vaccination</title><title>Infection</title><addtitle>Infection</addtitle><addtitle>Infection</addtitle><description>The seroepidemiology of hepatitis B in children living in Greece 6 years post-implementation of universal infant immunization (1998) was studied. We collected 90–100 sera/year of age, stratified by geographic region. The prevalence of HbsAg(+) was 0.6% (95% CI 0.3–1.3) whereas 4.5% (95% CI 3.4–5.9%) of children over 12 months of age had evidence of past HBV infection. A significant decline in the prevalence of past infection between children born before and after 1998 (5.5% vs 2.9%; RR = 1.9, 95% CI 1.03–3.5) was noted. Conversely, the prevalence of past HBV infection did not change significantly among immigrant children. Reinforcement of early vaccination of immigrant population is necessary.</description><subject>Adolescent</subject><subject>Analysis of Variance</subject><subject>Chi-Square Distribution</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Clinical and Epidemiological Study</subject><subject>Family Medicine</subject><subject>General Practice</subject><subject>Greece - epidemiology</subject><subject>Hepatitis</subject><subject>Hepatitis B - epidemiology</subject><subject>Hepatitis B - prevention &amp; control</subject><subject>Hepatitis B Antibodies - blood</subject><subject>Hepatitis B Core Antigens - immunology</subject><subject>Hepatitis B Surface Antigens - analysis</subject><subject>Hepatitis B Vaccines - administration &amp; dosage</subject><subject>Hepatitis B Vaccines - immunology</subject><subject>Hepatitis B virus</subject><subject>Hepatitis B virus - immunology</subject><subject>Humans</subject><subject>Immunization</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infectious Diseases</subject><subject>Internal Medicine</subject><subject>Longitudinal Studies</subject><subject>Mass Vaccination</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Seroepidemiologic Studies</subject><subject>Vaccines</subject><issn>0300-8126</issn><issn>1439-0973</issn><issn>1439-0972</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkU1rFTEUhoMo9lr9AW4kuHA3ek4yk49lvWhbKLjQCq7C3JmTNu1MMiZzhf57Z7wXCoK4CDlwnvcJ4WXsNcJ7BNAfCjaAUC1jpcGqSj1hG6ylrcBq-ZRtQAJUBoU6YS9KuQOAxtb6OTtBIyRqNBt2_5Vyoin0NIY0pJsHnjy_oKmdwxwK_8hD5OeZ6J5vb8PQZ4pc8R_U5sLP_EyZz7fEL8dpoJHivKRSXA3XMfyiXNqBf2-7LsQ_i5fsmW-HQq-O9ym7_vzp2_aiuvpyfrk9u6q6GmCuOjBeq10PrTG-bWoDtgcSy_FS7wxQTxaRCLtG9FYbiV4po9GLujHCgjxl7w7eKaefeyqzG0PpaBjaSGlfnLIIstHqv6AAo-sGxQK-_Qu8S_scl084gY1CWdvVhgeoy6mUTN5NOYxtfnAIbu3LHfpy67j25dbMm6N4vxupf0wcC1oAcQDKsoo3lB9f_rf1N8Sgn0I</recordid><startdate>20080401</startdate><enddate>20080401</enddate><creator>Papaevangelou, V.</creator><creator>Hadjichristodoulou, C.</creator><creator>Cassimos, D. C.</creator><creator>Pantelaki, K.</creator><creator>Tzivaras, A.</creator><creator>Hatzimichael, A.</creator><creator>Theodoridou, M.</creator><general>Urban &amp; Vogel</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20080401</creationdate><title>Seroepidemiology of Hepatitis B in Greek Children 6 Years After the Implementation of Universal Vaccination</title><author>Papaevangelou, V. ; Hadjichristodoulou, C. ; Cassimos, D. C. ; Pantelaki, K. ; Tzivaras, A. ; Hatzimichael, A. ; Theodoridou, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-c08f76bd0a88fa54809d0e2d0ef37b80ede911ee1c52d97831f66871f24582903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adolescent</topic><topic>Analysis of Variance</topic><topic>Chi-Square Distribution</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Clinical and Epidemiological Study</topic><topic>Family Medicine</topic><topic>General Practice</topic><topic>Greece - epidemiology</topic><topic>Hepatitis</topic><topic>Hepatitis B - epidemiology</topic><topic>Hepatitis B - prevention &amp; control</topic><topic>Hepatitis B Antibodies - blood</topic><topic>Hepatitis B Core Antigens - immunology</topic><topic>Hepatitis B Surface Antigens - analysis</topic><topic>Hepatitis B Vaccines - administration &amp; dosage</topic><topic>Hepatitis B Vaccines - immunology</topic><topic>Hepatitis B virus</topic><topic>Hepatitis B virus - immunology</topic><topic>Humans</topic><topic>Immunization</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infectious Diseases</topic><topic>Internal Medicine</topic><topic>Longitudinal Studies</topic><topic>Mass Vaccination</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Seroepidemiologic Studies</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Papaevangelou, V.</creatorcontrib><creatorcontrib>Hadjichristodoulou, C.</creatorcontrib><creatorcontrib>Cassimos, D. C.</creatorcontrib><creatorcontrib>Pantelaki, K.</creatorcontrib><creatorcontrib>Tzivaras, A.</creatorcontrib><creatorcontrib>Hatzimichael, A.</creatorcontrib><creatorcontrib>Theodoridou, M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Papaevangelou, V.</au><au>Hadjichristodoulou, C.</au><au>Cassimos, D. C.</au><au>Pantelaki, K.</au><au>Tzivaras, A.</au><au>Hatzimichael, A.</au><au>Theodoridou, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Seroepidemiology of Hepatitis B in Greek Children 6 Years After the Implementation of Universal Vaccination</atitle><jtitle>Infection</jtitle><stitle>Infection</stitle><addtitle>Infection</addtitle><date>2008-04-01</date><risdate>2008</risdate><volume>36</volume><issue>2</issue><spage>135</spage><epage>139</epage><pages>135-139</pages><issn>0300-8126</issn><eissn>1439-0973</eissn><eissn>1439-0972</eissn><abstract>The seroepidemiology of hepatitis B in children living in Greece 6 years post-implementation of universal infant immunization (1998) was studied. We collected 90–100 sera/year of age, stratified by geographic region. The prevalence of HbsAg(+) was 0.6% (95% CI 0.3–1.3) whereas 4.5% (95% CI 3.4–5.9%) of children over 12 months of age had evidence of past HBV infection. A significant decline in the prevalence of past infection between children born before and after 1998 (5.5% vs 2.9%; RR = 1.9, 95% CI 1.03–3.5) was noted. Conversely, the prevalence of past HBV infection did not change significantly among immigrant children. Reinforcement of early vaccination of immigrant population is necessary.</abstract><cop>Munich</cop><pub>Urban &amp; Vogel</pub><pmid>18231718</pmid><doi>10.1007/s15010-007-7096-6</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0300-8126
ispartof Infection, 2008-04, Vol.36 (2), p.135-139
issn 0300-8126
1439-0973
1439-0972
language eng
recordid cdi_proquest_miscellaneous_69103576
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adolescent
Analysis of Variance
Chi-Square Distribution
Child
Child, Preschool
Clinical and Epidemiological Study
Family Medicine
General Practice
Greece - epidemiology
Hepatitis
Hepatitis B - epidemiology
Hepatitis B - prevention & control
Hepatitis B Antibodies - blood
Hepatitis B Core Antigens - immunology
Hepatitis B Surface Antigens - analysis
Hepatitis B Vaccines - administration & dosage
Hepatitis B Vaccines - immunology
Hepatitis B virus
Hepatitis B virus - immunology
Humans
Immunization
Infant
Infant, Newborn
Infectious Diseases
Internal Medicine
Longitudinal Studies
Mass Vaccination
Medicine
Medicine & Public Health
Seroepidemiologic Studies
Vaccines
title Seroepidemiology of Hepatitis B in Greek Children 6 Years After the Implementation of Universal Vaccination
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T00%3A34%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Seroepidemiology%20of%20Hepatitis%20B%20in%20Greek%20Children%206%20Years%20After%20the%20Implementation%20of%20Universal%20Vaccination&rft.jtitle=Infection&rft.au=Papaevangelou,%20V.&rft.date=2008-04-01&rft.volume=36&rft.issue=2&rft.spage=135&rft.epage=139&rft.pages=135-139&rft.issn=0300-8126&rft.eissn=1439-0973&rft_id=info:doi/10.1007/s15010-007-7096-6&rft_dat=%3Cproquest_cross%3E1470177791%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=215613496&rft_id=info:pmid/18231718&rfr_iscdi=true